AJMC March 25, 2025
Skylar Jeremias

Key Takeaways

  • The AMCP meeting will address key trends, challenges, and innovations in managed care pharmacy, focusing on legislative impacts and high-cost drug strategies.
  • Site of service legislation and its impact on managed care strategies will be explored, emphasizing the balance between cost control and patient access.
  • The Inflation Reduction Act’s effects on Medicare Part D formulary design will be analyzed, highlighting unintended consequences for PBMs and health plans.
  • The potential of GLP-1 receptor agonists in treating conditions beyond diabetes will be discussed, with implications for formulary management and benefit design.

As managed care pharmacy navigates rapid transformations in policies, high-cost drug strategies, and innovative therapies, the upcoming AMCP annual meeting will provide critical insights into legislative impacts,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Pharma, Pharma / Biotech, Trends
23andMe bankruptcy: With America's DNA put on sale, market panic gets a new twist
The Case for 340B Done Right
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Novo Nordisk Lands Lexicon Pharma Obesity Drug With Potential to Pair With GLP-1s
Thermo Fisher, Chan Zuckerberg Institute partner to advance cellular imaging

Share This Article